PCOC
VRTX icon

Power Corp of Canada’s Vertex Pharmaceuticals VRTX Stock Holding History

Power Corp of Canada’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-14,156
Closed -$5.76M – 153
2023
Q4 		$5.76M Sell
14,156
-949
-6% -$351K 0.6% 52
2023
Q3 		$5.25M Hold
15,105
– – 0.33% 51
2023
Q2 		$5.32M Sell
15,105
-156
-1% -$52.6K 0.53% 55
2023
Q1 		$4.8M Buy
15,261
+14,218
+1,363% +$4.26M 0.49% 65
2022
Q4 		$301K Hold
1,043
– – 0.05% 132
2022
Q3 		$302K Buy
+1,043
New +$300K 0.07% 131

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Power Corp of Canada's VRTX Position: Q1 2024 in Review

Power Corp of Canada sold out of Vertex Pharmaceuticals (VRTX) in Q1 2024, closing a stake of 14,156 shares — an estimated $5.76M sold.

Power Corp of Canada first reported a position in VRTX in Q3 2022 and held it in 6 quarters. The position peaked at $5.76M in Q4 2023. 1,493 funds tracked by Wall St. Rank hold VRTX as of Q1 2024.

  • Power Corp of Canada reported no remaining Vertex Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Power Corp of Canada sold 14,156 Vertex Pharmaceuticals shares in Q1 2024, an estimated $5.76M.
  • Power Corp of Canada first reported a position in Vertex Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Power Corp of Canada's Vertex Pharmaceuticals position peaked at $5.76M in Q4 2023.
  • 1,493 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2024.

Based on Power Corp of Canada's 13F filing for Q1 2024, filed 14 May 2024.